R Squared LTD Day One Biopharmaceuticals, Inc. Transaction History
R Squared LTD
- $103 Billion
- Q4 2024
A detailed history of R Squared LTD transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, R Squared LTD holds 2,450 shares of DAWN stock, worth $30,331. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,450Holding current value
$30,331% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
179Shares Held
84.2MCall Options Held
144KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$97.5 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$79.6 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$72.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$60.3 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$56.1 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $909M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...